Awareness of COVID-19 in Turkey

NCT ID: NCT04357886

Last Updated: 2021-03-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2605 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-05-15

Study Completion Date

2020-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Because COVID-19 is a new virus, it is believed that awareness assessment will inform and guide what steps should be taken and which groups should be targeted in terms of controlling the pandemic. According to our hypothesis, COVID-19 awareness of individuals in different age groups in the Turkish population also varies. There are controlling pratices based on scientific studies made during the outbreak, but there is no certainty as to how much these measures are known by our society. Based on these, the aim of our study was to investigate and compare the awareness of new Coronavirus (COVID-19) in different age groups across Turkey.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Statistical Analysis: In the statistical analysis of the data obtained at the end of the study, SPSS (Statistical Package for Social Sciences / SPSS 21.0) was analyzed using the statistical program. In the study, arithmetic averages are presented with tables and graphs as mean ± SD (standard deviation) and values indicated by counting in numbers (percent). Demographic information of the participants and their responses to the questionnaire questions were evaluated using descriptive statistical analysis method. In the study, Independent Sample t Test was used in parametric data and ANOVA was used in normal non-parametric data. In all analyzes, p \<0,05 was considered statistically significant.

Sampling: Sample size was calculated based on the number of questions asked. Accordingly, the number of questions multiplied by the formula of 60 is the lower limit (42\*60=2520). Considering the 20% probability of a drop-out and the fact that participants did not want to volunteer, it was decided to take 3150 people to the study. Consent will be obtained from the participants through a voluntary information form.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having at least primary education
* Being literate in Turkish
* There is a level of cooperation to understand the evaluations
* Agree to participate in the study

Exclusion Criteria

* Those with audio and visual problems that prevent communication
Minimum Eligible Age

15 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul University - Cerrahpasa

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Saliha Gürdal Karakelle

Research Assistant

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ipek Yeldan, PhD

Role: STUDY_DIRECTOR

Istanbul University - Cerrahpasa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istanbul University-Cerrahpasa

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.

Reference Type BACKGROUND
PMID: 32113704 (View on PubMed)

Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020 May;55(5):105951. doi: 10.1016/j.ijantimicag.2020.105951. Epub 2020 Mar 29.

Reference Type BACKGROUND
PMID: 32234466 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://who.sprinklr.com

access to current data about the COVID-19 in the world

http://covid19.saglik.gov.tr/

access to current data about the COVID-19 in Turkey

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

60350273-605.99-

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.